ES2077813T3 - Dispositivos implantables intraoculares e intraorbitales para la liberacion controlada de agentes farmacologicos. - Google Patents

Dispositivos implantables intraoculares e intraorbitales para la liberacion controlada de agentes farmacologicos.

Info

Publication number
ES2077813T3
ES2077813T3 ES91311112T ES91311112T ES2077813T3 ES 2077813 T3 ES2077813 T3 ES 2077813T3 ES 91311112 T ES91311112 T ES 91311112T ES 91311112 T ES91311112 T ES 91311112T ES 2077813 T3 ES2077813 T3 ES 2077813T3
Authority
ES
Spain
Prior art keywords
intraorbital
intraocular
controlled release
implantable devices
pharmacological agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91311112T
Other languages
English (en)
Inventor
Jean Marie Parel
Richard K Parrish
Lourdes Portugal
Karl R Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Application granted granted Critical
Publication of ES2077813T3 publication Critical patent/ES2077813T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/147—Implants to be inserted in the stroma for refractive correction, e.g. ring-like implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses or corneal implants; Artificial eyes
    • A61F2/16—Intraocular lenses
    • A61F2/1694—Capsular bag spreaders therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004—Rounded shapes, e.g. with rounded corners
    • A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00—Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902—Method of implanting
    • Y10S623/905—Eye
    • Y10S623/907—Method of manipulating parts of intraocular lens structure for implantation

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Prostheses (AREA)

Abstract

SE DISPONEN UNA SERIE DE IMPLANTES PARA USO INTRAOCULAR Y/O INTRAORBITAL QUE PERMITEN LA LIBERACION CONTROLADA DE AGENTES FARMACEUTICOS. LOS IMPLANTES (10) SON BASICAMENTE CIRCULARES O PARCIALMENTE CIRCULARES, POR EJEMPLO ANILLOS EN FORMA DE C Y SE INSERTAN POR MEDIO DE INCISIONES (14) REALIZADAS EN LA PARED DEL OJO O SE SUTURAN ALREDEDOR DEL GLOBO OCULAR. LOS ANILLOS EN FORMA DE C PUEDEN FORMARSE DE POLIMEROS BIODEGRADABLES PARA LIBERAR UN MEDICAMENTO COMO POLIMEROS BIODEGRADABLES O EL IMPLANTE PUEDE TENER FORMA DE UNA ENVOLTURA POLIMERICA FLEXIBLE HUECA CON EL MEDICAMENTO EN SU INTERIOR PARA LIBERACION LENTA POR OSMOSIS.
ES91311112T 1989-03-23 1991-11-29 Dispositivos implantables intraoculares e intraorbitales para la liberacion controlada de agentes farmacologicos. Expired - Lifetime ES2077813T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32798989A 1989-03-23 1989-03-23

Publications (1)

Publication Number Publication Date
ES2077813T3 true ES2077813T3 (es) 1995-12-01

Family

ID=23279013

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91311112T Expired - Lifetime ES2077813T3 (es) 1989-03-23 1991-11-29 Dispositivos implantables intraoculares e intraorbitales para la liberacion controlada de agentes farmacologicos.

Country Status (5)

Country Link
US (1) US5098443A (es)
EP (1) EP0544948B1 (es)
DE (1) DE69113470T2 (es)
ES (1) ES2077813T3 (es)
RU (1) RU2099031C1 (es)

Families Citing this family (230)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
MX9301821A (es) * 1992-03-30 1994-03-31 Alza Corp Sistema de matriz polimerica biodegradable regulador de degradacion y metodo de tratamiento del mismo.
US5178635A (en) * 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US5354331A (en) * 1992-07-15 1994-10-11 Schachar Ronald A Treatment of presbyopia and other eye disorders
WO1994003129A1 (en) * 1992-08-07 1994-02-17 Keravision Inc. Hybrid intrastromal corneal ring
US6966927B1 (en) 1992-08-07 2005-11-22 Addition Technology, Inc. Hybrid intrastromal corneal ring
JP3727651B2 (ja) * 1992-09-03 2005-12-14 ケラビジョン，インコーポレイテッド 乱視矯正用の角膜実質内リング
US5323788A (en) * 1992-09-21 1994-06-28 Keravision Overlapping split ring device for corneal curvature adjustment
US5300118A (en) * 1992-09-21 1994-04-05 Keravision Adjustable devices for corneal curvature adjustment
US5707643A (en) * 1993-02-26 1998-01-13 Santen Pharmaceutical Co., Ltd. Biodegradable scleral plug
DE69425411T2 (de) * 1993-02-26 2001-02-08 Santen Pharmaceutical Co., Ltd Biologisch abbaubarer sklerastopfen
AU727908C (en) * 1993-08-02 2001-10-18 Keravision, Inc. Segmented pre-formed intrastromal corneal insert
DE69433625T2 (de) * 1993-08-02 2005-02-03 Addition Technology, Inc., Des Plaines Zusammenlegbarer, intrastromaler, kornealer einsatz aus mehreren segmenten
SG52643A1 (en) 1993-08-02 1998-09-28 Keravision Inc Segmented preformed intrastromal corneal insert
US5876438A (en) * 1993-08-02 1999-03-02 Houston Biotechnology Incorporated Polymeric device for the delivery of immunotoxins for the prevention of secondary cataract
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
AU731486B2 (en) * 1993-11-15 2001-03-29 Allergan, Inc. Biocompatible ocular implants
US5466233A (en) * 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
US6063396A (en) * 1994-10-26 2000-05-16 Houston Biotechnology Incorporated Methods and compositions for the modulation of cell proliferation and wound healing
US6063116A (en) * 1994-10-26 2000-05-16 Medarex, Inc. Modulation of cell proliferation and wound healing
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5612027A (en) * 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
ATE240698T1 (de) * 1995-06-07 2003-06-15 Keravision Inc Radiales intrastromales hornhautimplantat
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
DE19718826A1 (de) * 1997-05-05 1998-11-12 Marion S Dr Eckmiller Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung
US6135118A (en) 1997-05-12 2000-10-24 Dailey; James P. Treatment with magnetic fluids
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US20020055753A1 (en) * 1997-12-18 2002-05-09 Thomas A. Silvestrini Corneal implant methods and pliable implant therefor
US6050999A (en) * 1997-12-18 2000-04-18 Keravision, Inc. Corneal implant introducer and method of use
DE19818487C1 (de) * 1998-04-24 1999-09-30 Antonia J M Joussen Implantat in den Kapselsack in Verbindung mit einer Kataraktoperation
EP0958796B1 (de) * 1998-05-11 2003-10-15 Tobias Dr. Neuhann Intraokularlinse
US9962255B1 (en) * 1998-09-10 2018-05-08 Jeffrey N. Weiss One piece self-locking scleral buckle with placement instrument
FR2787991B1 (fr) * 1998-12-31 2001-05-25 Medicale De Prec S M P Sa Soc Dispositif pour traiter la presbytie ou autre affection oculaire
EP1173790A2 (en) 1999-03-01 2002-01-23 Boston Innovative Optics, Inc. System and method for increasing the depth of focus of the human eye
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
RU2202318C2 (ru) * 1999-05-18 2003-04-20 Красноярская государственная медицинская академия Способ пластики обнаженных костных структур орбиты
FR2794965B1 (fr) * 1999-06-21 2001-07-20 Ioltechnologie Production Anneau de tension intraoculaire pour la correction de la presbytie
US6702832B2 (en) 1999-07-08 2004-03-09 Med Logics, Inc. Medical device for cutting a cornea that has a vacuum ring with a slitted vacuum opening
RU2175223C2 (ru) * 1999-07-29 2001-10-27 Московский научно-исследовательский институт глазных болезней им. Гельмгольца Способ профилактики пролиферативной витреоретинопатии
US6699285B2 (en) * 1999-09-24 2004-03-02 Scieran Technologies, Inc. Eye endoplant for the reattachment of a retina
FR2801192B1 (fr) * 1999-11-19 2002-08-09 Corneal Ind Anneau pour sac capsulaire et ensemble constitue par un tel anneau et son injecteur
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
US20070031473A1 (en) * 2005-08-05 2007-02-08 Peyman Gholam A Drug delivery system and method
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US6638239B1 (en) 2000-04-14 2003-10-28 Glaukos Corporation Apparatus and method for treating glaucoma
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
ATE547080T1 (de) * 2000-08-30 2012-03-15 Univ Johns Hopkins Vorrichtungen zur intraokularen arzneimittelabgabe
US7181287B2 (en) * 2001-02-13 2007-02-20 Second Sight Medical Products, Inc. Implantable drug delivery device
AR032839A1 (es) * 2001-02-23 2003-11-26 Ras Holding Corp Instrumento quirurgico para hacer incisiones para implantes en la esclerotica ocular
US6713081B2 (en) * 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
US7488303B1 (en) * 2002-09-21 2009-02-10 Glaukos Corporation Ocular implant with anchor and multiple openings
US7678065B2 (en) * 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
US7094225B2 (en) * 2001-05-03 2006-08-22 Glaukos Corporation Medical device and methods of use of glaucoma treatment
EP2316394B1 (en) 2001-06-12 2016-11-23 The Johns Hopkins University Reservoir device for intraocular drug delivery
US20030078545A1 (en) * 2001-10-23 2003-04-24 Janet Howie System for administering a drug delivery device
GB2399753B (en) * 2002-01-18 2006-04-19 Michael E Snyder Method of making a sustained release ophthalmological device
US7186232B1 (en) * 2002-03-07 2007-03-06 Glaukoa Corporation Fluid infusion methods for glaucoma treatment
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US6899717B2 (en) * 2002-09-18 2005-05-31 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US7468065B2 (en) 2002-09-18 2008-12-23 Allergan, Inc. Apparatus for delivery of ocular implants
WO2004026106A2 (en) * 2002-09-18 2004-04-01 Allergan, Inc. Methods and apparatus for delivery of ocular implants
CA2689424A1 (en) * 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
BRPI0406858A (pt) * 2003-01-24 2006-01-03 Control Delivery Sys Inc Liberação controlada de agentes altamente solúveis
US8017135B1 (en) * 2003-01-31 2011-09-13 The Regents Of The University Of California Lipid-drug conjugates for local therapy of eye diseases
US7483750B2 (en) * 2003-03-21 2009-01-27 Second Sight Medical Products, Inc. Transretinal implant and method of implantation
US8404269B2 (en) 2003-04-11 2013-03-26 Michael Snyder Sustained release implantable eye device
US8021680B2 (en) 2003-05-02 2011-09-20 Surmodics, Inc. Controlled release bioactive agent delivery device
US8246974B2 (en) * 2003-05-02 2012-08-21 Surmodics, Inc. Medical devices and methods for producing the same
US7628810B2 (en) 2003-05-28 2009-12-08 Acufocus, Inc. Mask configured to maintain nutrient transport without producing visible diffraction patterns
NZ543864A (en) 2003-06-16 2009-10-30 Leuven K U Res & Dev Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
US8029477B2 (en) * 2003-12-19 2011-10-04 Ethicon Endo-Surgery, Inc. Applier with safety for implantable medical device
US20050046794A1 (en) * 2003-06-17 2005-03-03 Silvestrini Thomas A. Method and apparatus for aligning a mask with the visual axis of an eye
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050203333A1 (en) * 2003-12-15 2005-09-15 Dailey James P. Magnetized scleral buckle, polymerizing magnetic polymers, and other magnetic manipulations in living tissue
US7976520B2 (en) * 2004-01-12 2011-07-12 Nulens Ltd. Eye wall anchored fixtures
US7276050B2 (en) 2004-03-02 2007-10-02 Alan Franklin Trans-scleral drug delivery method and apparatus
US20050232972A1 (en) * 2004-04-15 2005-10-20 Steven Odrich Drug delivery via punctal plug
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
EP1611879B1 (en) * 2004-07-02 2009-08-12 Novagali Pharma SA Use of emulsions for intra- and periocular injection
WO2006014484A2 (en) * 2004-07-02 2006-02-09 Surmodics, Inc. Methods and devices for the treatment of ocular conditions
AU2005269988B2 (en) * 2004-07-02 2012-02-02 Mati Therapeutics Inc. Treatment medium delivery device and methods for delivery
WO2006043965A1 (en) * 2004-10-14 2006-04-27 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
CA2601864A1 (en) * 2005-04-08 2006-10-19 Surmodics, Inc. Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease
US7976577B2 (en) * 2005-04-14 2011-07-12 Acufocus, Inc. Corneal optic formed of degradation resistant polymer
US20060292222A1 (en) * 2005-06-21 2006-12-28 Matthew Jonasse Drug delivery device having zero or near zero-order release kinetics
US20070212397A1 (en) * 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
CN101304708B (zh) * 2005-10-31 2011-06-22 生立生物科技股份有限公司 巩膜环扣带及其制法
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
WO2007065149A2 (en) * 2005-12-01 2007-06-07 Innfocus, Llc Ocular implant
KR20090006153A (ko) * 2006-03-31 2009-01-14 큐엘티 플러그 딜리버리, 인코포레이티드 비루관계에 대한 약물 전달 방법, 구조, 및 조성물
US7981096B2 (en) * 2006-05-12 2011-07-19 David Castillejos Optic nerve head implant and medication delivery system
US7811252B2 (en) * 2006-05-17 2010-10-12 Alcon Research, Ltd. Dosage control device
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US8852256B2 (en) 2010-11-15 2014-10-07 Aquesys, Inc. Methods for intraocular shunt placement
AU2007269259B2 (en) * 2006-06-30 2012-05-31 Aquesys Inc. Methods, systems and apparatus for relieving pressure in an organ
US8974511B2 (en) 2010-11-15 2015-03-10 Aquesys, Inc. Methods for treating closed angle glaucoma
US8721702B2 (en) 2010-11-15 2014-05-13 Aquesys, Inc. Intraocular shunt deployment devices
US8801766B2 (en) 2010-11-15 2014-08-12 Aquesys, Inc. Devices for deploying intraocular shunts
US20120123316A1 (en) 2010-11-15 2012-05-17 Aquesys, Inc. Intraocular shunts for placement in the intra-tenon's space
US10085884B2 (en) 2006-06-30 2018-10-02 Aquesys, Inc. Intraocular devices
US8308701B2 (en) 2010-11-15 2012-11-13 Aquesys, Inc. Methods for deploying intraocular shunts
US8663303B2 (en) 2010-11-15 2014-03-04 Aquesys, Inc. Methods for deploying an intraocular shunt from a deployment device and into an eye
US9095411B2 (en) 2010-11-15 2015-08-04 Aquesys, Inc. Devices for deploying intraocular shunts
US8911496B2 (en) 2006-07-11 2014-12-16 Refocus Group, Inc. Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
MX357548B (es) * 2006-07-11 2018-07-13 Refocus Group Inc Star Prótesis escleral para tratar presbiopia y otros trastornos del ojo y dispositivos y métodos relacionados.
MX364494B (es) 2006-07-11 2019-04-29 Refocus Group Inc Star Aparato y metodo para asegurar tejido ocular.
US9039761B2 (en) * 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
ATE539102T1 (de) * 2006-10-31 2012-01-15 Surmodics Pharmaceuticals Inc Kugelförmige polymer-partikel
ES2523681T3 (es) * 2007-08-02 2014-11-28 Refocus Group, Inc. Prótesis escleral que tiene varillas transversales para tratar la presbicia y otros trastornos del ojo
US20110236501A1 (en) * 2007-09-05 2011-09-29 Vanderbilt University Injectable dual delivery allograph bone/polymer composite for treatment of open fractures
AU2008300013A1 (en) * 2007-09-07 2009-03-19 Qlt Inc. Drug cores for sustained release of therapeutic agents
US9011361B2 (en) 2007-09-07 2015-04-21 Mati Therapeutics Inc. Lacrimal implant detection
US8480638B2 (en) * 2007-10-04 2013-07-09 Aciont, Inc. Intraocular iontophoretic device and associated methods
US9849027B2 (en) 2007-11-08 2017-12-26 Alimera Sciences, Inc. Ocular implantation device
USD592746S1 (en) 2007-11-08 2009-05-19 Alimera Sciences Ocular implantation device
WO2009097468A2 (en) 2008-01-29 2009-08-06 Kliman Gilbert H Drug delivery devices, kits and methods therefor
TWI444384B (zh) 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
JP5552482B2 (ja) 2008-04-30 2014-07-16 キュー エル ティー インク． 複合涙管挿入物および関連する方法
EP2276492A2 (en) * 2008-05-09 2011-01-26 QLT Plug Delivery, Inc. Sustained release delivery of active agents to treat glaucoma and ocular hypertension
JP5591226B2 (ja) * 2008-05-12 2014-09-17 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション 眼内薬物送達装置および関連する方法
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US9095404B2 (en) 2008-05-12 2015-08-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
TWI531362B (zh) 2008-07-21 2016-05-01 艾爾康股份有限公司 具有治療劑遞送能力之眼科裝置
EP2334686B1 (en) 2008-08-28 2019-02-27 President and Fellows of Harvard College Cortistatin analogues and syntheses therof
CN101386203B (zh) * 2008-10-15 2011-09-14 广州卫视博生物科技有限公司 折叠式人工玻璃体制造方法及其模具
CN102292050A (zh) * 2008-11-19 2011-12-21 瑞福克斯集团公司 人造眼内晶状体、经改变的自然晶状体、或用于改进性能的带有一个或多个巩膜假体的再填充的自然晶状体囊体
US9943402B2 (en) 2008-11-20 2018-04-17 Insight Innovations, Llc Micropatterned intraocular implant
US20120232649A1 (en) * 2008-11-20 2012-09-13 Insight Innovations, Llc Intraocular Lens Cell Migration Inhibition System
US8551167B2 (en) 2008-11-20 2013-10-08 Insight Innovations, Llc Intraocular implant cell migration inhibition system
MX2011005272A (es) * 2008-11-20 2011-06-21 Insight Innovations Llc Sistema de implante intraocular biocompatible biodegradable.
JP2012509737A (ja) * 2008-11-26 2012-04-26 サーモディクス，インコーポレイティド 埋め込み式の眼薬送達器具および眼薬送達方法
US8545554B2 (en) * 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
CA2757037C (en) 2009-01-29 2019-08-06 Forsight Vision4, Inc. Posterior segment drug delivery
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
WO2010101758A1 (en) * 2009-03-03 2010-09-10 Alcon Research, Ltd. Peri-corneal drug delivery device
US20100292788A1 (en) * 2009-04-27 2010-11-18 Morris Robert E Unitary scleral buckling element and methods of using same
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP5937004B2 (ja) 2009-05-18 2016-06-22 ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 薬剤溶出眼内インプラント
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
ES2970433T3 (es) 2009-08-13 2024-05-28 Acufocus Inc Método de fabricación de implantes intraoculares con máscara y lentes
US10004593B2 (en) 2009-08-13 2018-06-26 Acufocus, Inc. Intraocular lens with elastic mask
US9427311B2 (en) 2009-08-13 2016-08-30 Acufocus, Inc. Corneal inlay with nutrient transport structures
US8808257B2 (en) * 2009-08-31 2014-08-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus for pulsatile release of medicaments from a punctal plug
USD656526S1 (en) 2009-11-10 2012-03-27 Acufocus, Inc. Ocular mask
US20110238036A1 (en) * 2009-12-23 2011-09-29 Psivida Us, Inc. Sustained release delivery devices
US8343106B2 (en) * 2009-12-23 2013-01-01 Alcon Research, Ltd. Ophthalmic valved trocar vent
RU2555120C2 (ru) * 2009-12-23 2015-07-10 Алькон Рисерч, Лтд. Офтальмологическая троакарная канюля с клапаном
US10166142B2 (en) 2010-01-29 2019-01-01 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
GB201011313D0 (en) 2010-07-05 2010-08-18 Ucl Business Plc Implantation devices, methods and implants
EP2600876B1 (en) 2010-08-05 2015-04-29 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
WO2012019136A2 (en) 2010-08-05 2012-02-09 Forsight Vision 4, Inc. Injector apparatus and method for drug delivery
PT2600812T (pt) 2010-08-05 2021-11-09 Forsight Vision4 Inc Aparelho para tratar um olho
US10842671B2 (en) 2010-11-15 2020-11-24 Aquesys, Inc. Intraocular shunt placement in the suprachoroidal space
WO2012068549A2 (en) 2010-11-19 2012-05-24 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
WO2012149452A1 (en) 2011-04-29 2012-11-01 Regents Of The University Of Michigan Compounds, formulations, and methods of protein kinase c inhibition
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
WO2013003620A2 (en) 2011-06-28 2013-01-03 Forsight Vision4, Inc. Diagnostic methods and apparatus
US8597318B2 (en) 2011-08-08 2013-12-03 Refocus Group, Inc. Apparatus and method for forming incisions in ocular tissue
EP2755549A1 (en) 2011-09-13 2014-07-23 Dose Medical Corporation Intraocular physiological sensor
CA2848397C (en) 2011-09-14 2022-04-26 Forsight Vision5, Inc. Ocular insert apparatus and methods
ES2864203T3 (es) 2011-09-16 2021-10-13 Forsight Vision4 Inc Aparato de intercambio de fluido
JP6046160B2 (ja) 2011-12-02 2016-12-14 アキュフォーカス・インコーポレーテッド 選択的分光透過性を有する眼科マスク
US9610195B2 (en) 2013-02-27 2017-04-04 Aquesys, Inc. Intraocular shunt implantation methods and devices
US9808373B2 (en) 2013-06-28 2017-11-07 Aquesys, Inc. Intraocular shunt implantation
US10080682B2 (en) 2011-12-08 2018-09-25 Aquesys, Inc. Intrascleral shunt placement
US8852136B2 (en) 2011-12-08 2014-10-07 Aquesys, Inc. Methods for placing a shunt into the intra-scleral space
US8765210B2 (en) 2011-12-08 2014-07-01 Aquesys, Inc. Systems and methods for making gelatin shunts
US9241829B2 (en) * 2011-12-20 2016-01-26 Abbott Medical Optics Inc. Implantable intraocular drug delivery apparatus, system and method
WO2013116061A1 (en) 2012-02-03 2013-08-08 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
WO2013124477A1 (en) 2012-02-24 2013-08-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
US9827401B2 (en) 2012-06-01 2017-11-28 Surmodics, Inc. Apparatus and methods for coating medical devices
CA2874824C (en) 2012-06-01 2021-10-26 Surmodics, Inc. Apparatus and methods for coating balloon catheters
US20150209274A1 (en) * 2012-08-15 2015-07-30 Nanyang Technological University Drug eluting member, a method of attaching the same and a method of fabricating the same, a device for holding the same and a drug eluting device
KR101400701B1 (ko) * 2012-10-19 2014-05-30 주식회사 루시드코리아 백내장 수술용 전낭절개 가이드 장치
WO2014066775A1 (en) 2012-10-26 2014-05-01 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
US10159600B2 (en) 2013-02-19 2018-12-25 Aquesys, Inc. Adjustable intraocular flow regulation
US9125723B2 (en) 2013-02-19 2015-09-08 Aquesys, Inc. Adjustable glaucoma implant
US9204962B2 (en) 2013-03-13 2015-12-08 Acufocus, Inc. In situ adjustable optical mask
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
EP2968113B8 (en) 2013-03-14 2020-10-28 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US9427922B2 (en) 2013-03-14 2016-08-30 Acufocus, Inc. Process for manufacturing an intraocular lens with an embedded mask
CN105246438B (zh) 2013-03-28 2018-01-26 弗赛特影像4股份有限公司 用于输送治疗物质的眼科植入物
US20150100046A1 (en) * 2013-10-09 2015-04-09 Balamurali K. Ambati Intraocular drug delivery device and associated methods
MX2016006297A (es) 2013-11-14 2016-07-26 Aquesys Inc Insertador de derivacion intraocular.
SG11201605178WA (en) 2013-12-24 2016-07-28 Harvard College Cortistatin analogues and syntheses and uses thereof
AU2015266850B2 (en) 2014-05-29 2019-12-05 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
MX384889B (es) 2014-07-15 2025-03-14 Forsight Vision4 Inc Dispositivo y metodo de entrega de implante ocular.
KR20170040798A (ko) 2014-08-08 2017-04-13 포사이트 비젼4, 인크. 수용체 티로신 키나제 억제제의 안정한 가용성 제제 및 그의 제조 방법
EP3217924B1 (en) 2014-11-10 2025-07-16 ForSight Vision4, Inc. Expandable drug delivery devices
FR3028410A1 (fr) 2014-11-18 2016-05-20 Pierre Coulon Implant capsulaire multifonctionnel
EP3220859B8 (en) 2014-11-19 2020-06-10 AcuFocus, Inc. Fracturable mask for treating presbyopia
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
WO2016182932A1 (en) 2015-05-08 2016-11-17 President And Fellows Of Harvard College Cortistatin analogues, syntheses, and uses thereof
AU2016268867B2 (en) 2015-05-28 2021-11-11 Page Surgical Innovations, Llc Capsular tension ring inserter and method
JP6916742B2 (ja) 2015-06-03 2021-08-11 アクエシス， インコーポレイテッド Ａｂ ｅｘｔｅｒｎｏ（眼外から眼内へ）の眼内シャント配置
EP3316889A4 (en) 2015-07-01 2018-11-14 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US10687935B2 (en) 2015-10-05 2020-06-23 Acufocus, Inc. Methods of molding intraocular lenses
KR20180084104A (ko) 2015-11-20 2018-07-24 포사이트 비젼4, 인크. 연장 방출 약물 전달 장치를 위한 다공성 구조물
CA3005891C (en) 2015-11-24 2023-12-12 Acufocus, Inc. Toric small aperture intraocular lens with extended depth of focus
AU2017221441A1 (en) 2016-02-17 2018-10-04 Children's Medical Center Corporation FFA1 (GPR40) as a therapeutic target for neural angiogenesis diseases or disorders
US11617680B2 (en) 2016-04-05 2023-04-04 Forsight Vision4, Inc. Implantable ocular drug delivery devices
CA3022830A1 (en) 2016-04-20 2017-10-26 Harold Alexander Heitzmann Bioresorbable ocular drug delivery device
BR112018074389A2 (pt) 2016-06-02 2019-03-06 Aquesys, Inc. envio de fármaco intraocular
CN111225624A (zh) 2017-08-23 2020-06-02 瑞福克斯集团公司 一种用于在眼部组织形成切口且具有提供可视性端头的外科手术工具及其相关装置和方法
US11246753B2 (en) 2017-11-08 2022-02-15 Aquesys, Inc. Manually adjustable intraocular flow regulation
CN115607358A (zh) 2017-11-21 2023-01-17 弗赛特影像4股份有限公司 用于可扩展端口递送系统的流体交换装置及使用方法
US12305185B2 (en) 2018-01-23 2025-05-20 Mount Spec Investments Pty Ltd Expression vector and method
WO2019161378A1 (en) 2018-02-19 2019-08-22 University Of Miami Cyclophosphamide for treating ophthalmic inflammation
US10952898B2 (en) 2018-03-09 2021-03-23 Aquesys, Inc. Intraocular shunt inserter
US11135089B2 (en) 2018-03-09 2021-10-05 Aquesys, Inc. Intraocular shunt inserter
EP3790508B1 (en) 2018-05-09 2026-04-29 AcuFocus, Inc. Intraocular implant with optic
WO2020112816A1 (en) 2018-11-29 2020-06-04 Surmodics, Inc. Apparatus and methods for coating medical devices
US11819590B2 (en) 2019-05-13 2023-11-21 Surmodics, Inc. Apparatus and methods for coating medical devices
CA3149866A1 (en) 2019-10-24 2021-04-29 Denis E. Labombard Ocular device and drug delivery system, with case
WO2021174039A1 (en) 2020-02-28 2021-09-02 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
US11571333B2 (en) 2020-05-18 2023-02-07 Refocus Group, Inc. Apparatus and method for securing ocular tissue and providing surgical tool positioning points
US12496612B2 (en) 2021-01-08 2025-12-16 Surmodics, Inc. Coating application system and methods for coating rotatable medical devices
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
USD1137672S1 (en) 2024-08-27 2026-07-28 Glaukos Corporation Drug eluting ocular implant

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995635A (en) * 1971-09-09 1976-12-07 Alza Corporation Ocular insert
GB1529143A (en) * 1977-08-22 1978-10-18 Alza Corp Ocular inserts
US4300557A (en) * 1980-01-07 1981-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating intraocular malignancies
US4439198A (en) * 1981-07-09 1984-03-27 University Of Illinois Foundation Biodegradable ocular insert for controlled delivery of ophthalmic medication
US4573998A (en) * 1982-02-05 1986-03-04 Staar Surgical Co. Methods for implantation of deformable intraocular lenses
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4731080A (en) * 1985-01-18 1988-03-15 Galin Miles A Coated intraocular lens
SE8505518D0 (sv) * 1985-11-22 1985-11-22 Swedish Graft Tech Ab Implantationslins, forfarande for framsstellning derav och anordning for att utfora forfarandet
US4919130A (en) * 1986-11-07 1990-04-24 Nestle S.A. Tool for inserting compressible intraocular lenses into the eye and method
US4863457A (en) * 1986-11-24 1989-09-05 Lee David A Drug delivery device
US4955906A (en) * 1989-01-12 1990-09-11 Coggins Peter R Mammary prosthesis injector

Also Published As

Publication number Publication date
EP0544948A1 (en) 1993-06-09
RU2099031C1 (ru) 1997-12-20
DE69113470T2 (de) 1996-03-07
US5098443A (en) 1992-03-24
EP0544948B1 (en) 1995-09-27
DE69113470D1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
AR020155A1 (es) Revestimiento corneo o un implante corneo que se va a colocar adentro o sobre la superficie de la cornea, que es un material polimerico biocompatible,opticamente transparente, sintetico y bioestable, comprendiendo este material una superficie que soporta la union y el crecimiento de celulas detejido
NO955361L (no) Organiske aerogeler
ES2040719T3 (es) Recubrimiento bioabsorbible para un articulo quirurgico.
CY1105496T1 (el) Αορτικο εμφυτευμα για τη θεραπευτικη αντιμετωπιση κοιλιακων αορτικων ανευρυσματων και χρηση του εμφυτευματος
ES2167611T3 (es) Formulaciones de gel que contienen factores de crecimiento.
ES2065166T3 (es) Superficie de fijacion porosa.
CA2030459A1 (en) Biodegradable ocular implants
CN102090946B (zh) 用襻丝做眼内固定的人工晶体囊袋
AR004545A1 (es) Derivados de purin-6-ona, procedimientos para su preparacion, el uso de los mismos en la preparacion de medicamentos, medicamentos que los contieneny un procedimiento para preparar dichos medicamentos
ES2107588T3 (es) Endoprotesis implantable en forma percutanea en el cuerpo de un paciente.
AU7088791A (en) Inflatable stent
ES2173273T3 (es) Articulo de tejido con indicador de extension.
WO1996013286A3 (en) Modulation of cell proliferation and wound healing
ATE292430T1 (de) Implantierbare medizinische vorrichtung mit verbesserter biokompatibilität und biostabilität
ES2051882T3 (es) Composicion que comprende implantes oculares biodegradables.
ATE183106T1 (de) Einstellbare vorrichtungen für die einstellung der hornhautkrümmung
DK0621766T3 (da) Hornhindeækvivalent-in-vitro-model
JPH01500011A (ja) 眼内移植レンズ
GB1291470A (en) A device for mounting a prosthesis on skeletal tissue
DE69626996D1 (de) Unter gewebebedingungen abbaubares material und verfahren zu seiner herstellung
ES2182839T3 (es) Manguito de infusion de fluido nuevo y mejorado.
AU2001252659A1 (en) Stent Holding member and Stent Delivery System
ES2077397T3 (es) Canales guia biodegradables y bioabsorbibles para utilizacion en tratamiento y regeneracion de nervios.
ES2023095T3 (es) Cateter con zona en forma globular.
ES2111072T3 (es) Sistemas de extrusion de capsulas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 544948

Country of ref document: ES